Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

SELL
$8.01 - $8.64 $680 - $734
-85 Reduced 0.39%
21,727 $179,000
Q1 2024

May 06, 2024

SELL
$8.02 - $8.67 $22,119 - $23,911
-2,758 Reduced 11.23%
21,812 $185,000
Q4 2023

Feb 08, 2024

SELL
$7.78 - $8.62 $30.2 Million - $33.5 Million
-3,885,806 Reduced 99.37%
24,570 $202,000
Q3 2023

Nov 07, 2023

BUY
$7.85 - $8.94 $81,263 - $92,546
10,352 Added 0.27%
3,910,376 $32.6 Million
Q2 2023

Aug 02, 2023

SELL
$8.04 - $9.0 $695,709 - $778,779
-86,531 Reduced 2.17%
3,900,024 $32.7 Million
Q1 2023

May 03, 2023

BUY
$7.57 - $8.37 $1.63 Million - $1.8 Million
215,295 Added 5.71%
3,986,555 $32.5 Million
Q4 2022

Feb 07, 2023

BUY
$5.96 - $8.06 $2.8 Million - $3.78 Million
469,110 Added 14.21%
3,771,260 $30.2 Million
Q3 2022

Nov 09, 2022

BUY
$5.63 - $7.5 $18.6 Million - $24.8 Million
3,302,150 New
3,302,150 $20.1 Million

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $45.1B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Equity Investment Corp Portfolio

Follow Equity Investment Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Equity Investment Corp, based on Form 13F filings with the SEC.

News

Stay updated on Equity Investment Corp with notifications on news.